Clinical trial
Tofacitinib for the Treatment of Inflammatory Eye Disease
NCT03580343 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tofacitinib for the Treatment of Inflammatory Eye Disease
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- April 4, 2019
- Completion date
- April 4, 2021
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.